Previous studies have demonstrated that ghrelin can inhibit the reduction of obesity-induced myocardial injury by influencing the lncRNA H19/miR-29a/IGF-1 signaling pathway and the HOTAIR/miR-196b/IGF-1 signaling pathway [79,80]. Here, GHRL is linked to obesity disorder.